Pasar al contenido principal

ESTUDIO DE LOS MECANISMOS QUE RELACIONAN LAS PROPIEDADES DE LA MATRIX EXTRACELULAR Y LA REGENERACION/REPARACION CARDIACA

RTI2018-095377-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIO PRIVADA CENTRE DE MEDICINA REGENERATIVA DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration

  • Carola, G.
  • Malagarriga, D.
  • Calatayud, Carles
  • Pons-Espinal, M.
  • Blasco-Agell, Lucas
  • Richaud-Patin, Y.
  • Fernández-Carasa, Irene
  • Baruffi, V.
  • Beltramone, S.
  • Molina, E.
  • Dell’Era, P.
  • Toledo-Aral, Juan José
  • Tolosa, Eduard
  • Muotri , A. R.
  • García Ojalvo, J.
  • Soriano, J.
  • Raya, A.
  • Consiglio, Antonella
A deeper understanding of early disease mechanisms occurring in Parkinson’s disease (PD) is needed to reveal restorative targets. Here we report that human induced pluripotent stem cell (iPSC)-derived dopaminergic neurons (DAn) obtained from healthy individuals or patients harboring LRRK2 PD-causing mutation can create highly complex networks with evident signs of functional maturation over time. Compared to control neuronal networks, LRRK2 PD patients’ networks displayed an elevated bursting behavior, in the absence of neurodegeneration. By combining functional calcium imaging, biophysical modeling, and DAn-lineage tracing, we found a decrease in DAn neurite density that triggered overall functional alterations in PD neuronal networks. Our data implicate early dysfunction as a prime focus that may contribute to the initiation of downstream degenerative pathways preceding DAn loss in PD, highlighting a potential window of opportunity for pre-symptomatic assessment of chronic degenerative diseases., Research from the authors’ laboratories is supported by the European Research Council-ERC (2012-StG-311736-PD-HUMMODEL), the MESOBRAIN project from the European Union’s Horizon 2020 research and innovation (grant agreement No. 713140), the Spanish Ministry of Economy and Competitiveness-MINECO (RTI2018-095377-B-100, FIS2016-78507-C2-2-P, PID2019-108842GB-C21) the Spanish Ministry of Economy and Competitiveness-MINECO/AEI/FEDER, UE (BFU2016-80870-P) and the Spanish Ministry of Economy and Competitiveness- AEI/10.13039/501100011033 (PID2019-108792GB-I00), Instituto de Salud Carlos III-ISCIII/FEDER (Red de Terapia Celular - TerCel RD16/0011/0024 and RD16/0011/0025), AGAUR (2017-SGR-899 and 2017-SGR-1061), and CERCA Program/Generalitat de Catalunya. M.P.E. was partially supported by a Beatriu de Pinós fellowship from the Agency for Management of University and Research Grants (AGAUR) of the Government of Catalonia (2017 BP 00133). L.B. is the recipient of a pre-doctoral fellowship FPI (BES-2017-080579) from the Spanish Ministry of Economy and Competitiveness (MINECO). G.C. was partially supported by pre-doctoral fellowship from Spanish Economy and Competitiveness-MINECO (BES-2014-069603)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

iPSC-based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation

  • Tristán-Noguero, Alba
  • Fernández-Carasa, Irene
  • Calatayud, Carles
  • Bermejo-Casadesús, Cristina
  • Pons-Espinal, Meritxell
  • Colini Baldeschi, Arianna
  • Campa, Leticia
  • Artigas, Francesc
  • Bortolozzi, Analía
  • Domingo-Jiménez, Rosario
  • Ibáñez, Salvador
  • Pineda, Mercè
  • Artuch, Rafael
  • Raya, Ángel
  • García-Cazorla, Àngels
  • Consiglio, Antonella
Tyrosine hydroxylase deficiency (THD) is a rare genetic disorder leading to dopaminergic depletion and early-onset Parkinsonism. Affected children present with either a severe form that does not respond to L-Dopa treatment (THD-B) or a milder L-Dopa responsive form (THD-A). We generated induced pluripotent stem cells (iPSCs) from THD patients that were differentiated into dopaminergic neurons (DAn) and compared with control-DAn from healthy individuals and gene-corrected isogenic controls. Consistent with patients, THD iPSC-DAn displayed lower levels of DA metabolites and reduced TH expression, when compared to controls. Moreover, THD iPSC-DAn showed abnormal morphology, including reduced total neurite length and neurite arborization defects, which were not evident in DAn differentiated from control-iPSC. Treatment of THD-iPSC-DAn with L-Dopa rescued the neuronal defects and disease phenotype only in THDA-DAn. Interestingly, L-Dopa treatment at the stage of neuronal precursors could prevent the alterations in THDB-iPSC-DAn, thus suggesting the existence of a critical developmental window in THD. Our iPSC-based model recapitulates THD disease phenotypes and response to treatment, representing a promising tool for investigating pathogenic mechanisms, drug screening, and personalized management., The authors are indebted to the THD patients who have participated in this study. The authors thank Bernd Kuebler and Begoña Aran from the P-CMR[C] Stem Cell Bank, for generating the THD iPSCs. We would like to thank Marcia Triunfol and João Mello-Vieira at Publicase for their help with this manuscript. Research from the authors' laboratories is supported by the European Research Council-ERC (2012-StG-311736-PD-HUMMODEL) and ERC 2020-PoC (957581 NeurAntigen), the Spanish Ministry of Economy and Competitiveness-MINECO (PID2019-108792GB-I00, PID2019-105136RB-100, PID2021-123925OB-I00, PDC2021-121051-I00 and RTI2018-095377-B-100), supported by MCIN/AEI/10.13039/501100011033 and “NextGenerationEU/PRTR”, Instituto de Salud Carlos III-ISCIII/ and “Fondo Europeo de desarrollo regional” (FEDER) (Red de Terapia Celular - TerCel RD16/0011/0024, FIS PI15/01082, P118/00111), Agencia Estatal de Investigación-AEI (Unidad de Excelencia María de Maeztu CEX2018-000792-M), AGAUR (2017-SGR-899 and 2017-SGR-1061), Fundació la Marató de TV3 (202012-31 and 202012-32) and CERCA Programme/Generalitat de Catalunya. CC was partially supported by predoctoral fellowship (FPU12/03332) from the Spanish Ministry of Education (MEC). AT-N was partially supported by a PFIS pre-doctoral fellowship (FI14/00641) from the Instituto de Salud Carlos III-ISCIII and 2018BR-IRSJD-CdTorres from Sant Joan de Déu Hospital. AC is a recipient of an ICREA “Academia” Award (Generalitat de Catalunya)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Transplantation of human induced pluripotent stem cell-derived retinal pigment epithelium in a swine model of geographic atrophy

  • Duarri, Anna|||0000-0003-4075-5478
  • Rodríguez-Bocanegra, Eduardo|||0000-0003-3019-8911
  • Martínez-Navarrete, Gema|||0000-0002-9795-2846
  • Biarnés, Marc|||0000-0003-2584-4894
  • García, Miriam
  • Ferraro, Lucia Lee|||0000-0002-3741-1220
  • Kuebler, Bernd|||0000-0002-4472-871X
  • Aran, Begoña|||0000-0002-5011-7755
  • Izquierdo, Elisabeth
  • Aguilera-Xiol, Eli
  • Casaroli-Marano, Ricardo Pedro|||0000-0003-1812-9323
  • Trias, Esteve|||0000-0001-7635-4428
  • Fernandez, Eduardo|||0000-0002-7052-6011
  • Raya, Ángel|||0000-0003-2189-9775
  • Veiga, Anna|||0000-0002-0943-9904
  • Monés Carilla, Jordi|||0000-0003-3685-2160
Background: The aim of this study was to test the feasibility and safety of subretinal transplantation of human induced pluripotent stem cell (hiPSC)-derived retinal pigment epithelium (RPE) cells into the healthy margins and within areas of degenerative retina in a swine model of geographic atrophy (GA). Methods: Well-delimited selective outer retinal damage was induced by subretinal injection of NaIO3 into one eye in minipigs (n = 10). Thirty days later, a suspension of hiPSC-derived RPE cells expressing green fluorescent protein was injected into the subretinal space, into the healthy margins, and within areas of degenerative retina. In vivo follow-up was performed by multimodal imaging. Post-mortem retinas were analyzed by immunohistochemistry and histology. Results: In vitro differentiated hiPSC-RPE cells showed a typical epithelial morphology, expressed RPE-related genes, and had phagocytic ability. Engrafted hiPSC-RPE cells were detected in 60% of the eyes, forming mature epithelium in healthy retina extending towards the border of the atrophy. Histological analysis revealed RPE interaction with host photoreceptors in the healthy retina. Engrafted cells in the atrophic zone were found in a patchy distribution but failed to form an epithelial-like layer. Conclusions: These results might support the use of hiPSC-RPE cells to treat atrophic GA by providing a housekeeping function to aid the overwhelmed remnant RPE, which might improve its survival and therefore slow down the progression of GA.